Friday, September 12, 2025

Latest

Khiron Receives Authorization For Sale Of High-THC Medical Cannabis

Khiron Life Sciences (TSXV: KHRN) announced this morning that it has received authorization from the Colombian government to begin selling high-THC medical cannabis to patients. Khiron is the first, and currently only, company to receive authorization from the Colombian government for both the manufacturing and sale of high-THC medical cannabis.

The company itself refers to the authorization as having been for “magistral preparation” for high-THC medical cannabis, a term which is defined as “any medicinal product prepared in a pharmacy in accordance with a medical prescription for an individual patient.” The authorization enables the company to immediately begin selling high-THC medical products through its ILAN pharmacy network.

ILAN is fully authorized to sell high-THC products to patients for indications that include nausea, chronic pain, and vomiting associated with chemotherapy. Expanded distribution is expected to also occur as partner pharmacies receive approval to sell high-THC medical cannabis to patients, with the company giving a target of the third quarter of 2020 for this expanded distribution.

"The authorization from Colombia's National Narcotics Fund demonstrates our continued ability to meet regulatory requirements, and as a result we today begin to sell high-THC medical cannabis product in Colombia. With our clinics, training and infrastructure in place our high-THC product offers an important alternative for patients living with chronic pain, nausea and vomiting associated with chemotherapy, and continues Khiron's mission to improve the quality of life for patients in Colombia and across Latin America" 
Juan Diego Alvarez

Khiron Life Sciences last traded at $0.82 on the TSX Venture.


FULL DISCLOSURE: Khiron Life Sciences is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Khiron Life Sciences on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Avino Q2 Earnings: Steady As She Goes

MEG Energy: Cenovus Comes In With $7.9 BILLION Offer

Orla Mining Q2 Earnings: Musselwhite Changes Everything

Recommended

Northern Superior Expands Philibert With 350 Metre Step Out Testing 1.10 g/t Gold Over 25.5 Metres

Goliath Resources Hits 18.58 g/t Gold Over 5.00 Metres At Surebet

Related News

Khiron Launches Kuida CBD Skincare Products Into Hong Kong Market

Khiron Life Sciences (TSXV: KHRN) is going to Asia. The company announced this morning that...

Monday, August 10, 2020, 09:13:10 AM

Khiron To Conduct Live Virtual Tour Of New Medical Facility On July 21

What do you do when your investors are located thousands of miles away from your...

Friday, July 17, 2020, 08:51:42 AM

Khiron Imports First Product To UK, Receives First European Prescriptions

Khiron Life Sciences (TSXV: KHRN) has officially entered the United Kingdom’s medical cannabis market, announcing...

Wednesday, May 6, 2020, 08:34:00 AM

Khiron Life Sciences Records $2.8 Million In Revenue, $4.8 Million Net Loss In Q2 2021

Khiron Life Sciences Corp. (TSXV: KHRN) reported this morning its financial statements for the quarter...

Monday, August 23, 2021, 09:30:00 AM

Khiron Life Sciences To Conduct Share Buybacks

Khiron Life Sciences (TSXV: KHRN) announced this morning that it will be conducting a normal...

Tuesday, February 11, 2020, 09:20:58 AM